Researchers report the addition of an FDA approved chemotherapy drug called hydroxyyurea to temozolomide helps to increase survival rates in animal models of glioblastoma.
Arsenic trioxide, a treatment used for acute promyelocytic leukemia, may help extend lifespan in patients with glioblastoma brain cancer, a new study reports.
Temozolomide, a chemotherapy drug used to treat brain cancer, could increase risks of developing depression by preventing neurogenesis, a new study reports.
A lipid nanocarrier small enough to pass the blood-brain barrier could be an effective method for delivering chemotherapy medications to help fight glioblastoma brain tumors, a new study reports.
Researchers have discovered a way in which to sensitize drug-resistant human glioblastoma cells to chemotherapy.
Researchers report a combination of three different anti-cancer drugs shows promising results for the treatment of glioblastoma brain cancer.
Researchers suggest delivering chemotherapy directly into the brain cavity could offer a better way to treat tumors which have metastasized to the brain.
Recurrent gliomas could have genetic profiles which are different from those of the initial tumors that spawned them, a new study reports.
A new study argues that prolonged chemotherapy decreases the development of new brain cells, and disrupts ongoing brain rhythms in the part of the brain responsible for making new memories.
